Literature DB >> 22691952

Microinjection of RFRP-1 in the central nucleus of amygdala decreases food intake in the rat.

Anita Kovács1, Kristóf László, Rita Gálosi, Krisztián Tóth, Tamás Ollmann, László Péczely, László Lénárd.   

Abstract

Several members of the RFamide peptide family are known to have role in the regulation of feeding. For example, neuropeptide FF and prolactin-releasing peptide cause anorexigenic, while 26RFa and QRFP result in orexigenic effects in rodents. I.c.v. microinjection of neuropeptide RFRP-1 significantly reduced food and water intake in chicks. However, feeding related effects of RFRP-1 have not been studied in mammals yet. The central part of amygdala (CeA) is essentially involved in the regulation of feeding and body weight. RFRP-1 positive nerve cells were detected in the rat hypothalamus and RFRP-1 immunoreactive fibers were identified in the CeA. RFRP analogs bind with relatively high affinity to the NPFF1 and NPFF2 receptors (NPFF-R). RFRP-1 has potent activity for NPFF1. Significant expression of NPFF1 was detected in the CeA. To evaluate the role of RFRP-1 in feeding regulation rats were microinjected with different doses of RFRP-1 and their food intake were quantified over a 60min period. Liquid food intake of male Wistar rats was measured after bilateral intraamygdaloid administration of RFRP-1 (25, 50 or 100ng/side, RFRP-1 dissolved in 0.15M sterile NaCl/0.4μl, respectively). The 50ng dose of RFRP-1 microinjections resulted in significant decrease of food intake. The 25 and 100ng had no effect. Action of 50ng (37.8pmol) RFRP-1 was eliminated by 20ng (41.4pmol) RF9 NPFF-R antagonist pretreatment. In open-field test 50ng RFRP-1 did not modify spontaneous locomotor activity and general behavior of animals did not change. Our results are the first reporting that RFRP-1 injected to the CeA result in a decrease of liquid food consumption. This is a receptor-linked effect because it was eliminated by a NPFF-R selective antagonist.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691952     DOI: 10.1016/j.brainresbull.2012.06.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  7 in total

Review 1.  RF-amide related peptide-3 (RFRP-3): a novel neuroendocrine regulator of energy homeostasis, metabolism, and reproduction.

Authors:  Shabana Anjum; Muhammad Nasir Khan Khattak; Kazuyoshi Tsutsui; Amitabh Krishna
Journal:  Mol Biol Rep       Date:  2021-02-10       Impact factor: 2.316

2.  Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performance.

Authors:  Ruthann Nichols; Chloe Bass; Leslie Demers; Brian Larsen; Elton Li; Nathan Blewett; Kimber Converso-Baran; Mark W Russell; Margaret V Westfall
Journal:  J Med Chem       Date:  2012-08-30       Impact factor: 7.446

3.  Hypothalamic QRFP: regulation of food intake and fat selection.

Authors:  S D Primeaux; M J Barnes; H D Braymer
Journal:  Horm Metab Res       Date:  2013-08-26       Impact factor: 2.936

4.  Central amygdala PKC-δ(+) neurons mediate the influence of multiple anorexigenic signals.

Authors:  Haijiang Cai; Wulf Haubensak; Todd E Anthony; David J Anderson
Journal:  Nat Neurosci       Date:  2014-07-27       Impact factor: 24.884

Review 5.  The roles of RFamide-related peptides (RFRPs), mammalian gonadotropin-inhibitory hormone (GnIH) orthologues in female reproduction.

Authors:  Huimei Wang; Arezoo Khoradmehr; Mohammad Jalali; Mohammad Saied Salehi; Kazuyoshi Tsutsui; Mohammad Reza Jafarzadeh Shirazi; Amin Tamadon
Journal:  Iran J Basic Med Sci       Date:  2018-12       Impact factor: 2.699

Review 6.  Anxiety and Depression: What Do We Know of Neuropeptides?

Authors:  Ida Kupcova; Lubos Danisovic; Ivan Grgac; Stefan Harsanyi
Journal:  Behav Sci (Basel)       Date:  2022-07-29

Review 7.  The Role of GnIH in Biological Rhythms and Social Behaviors.

Authors:  Chuin Hau Teo; Brandon Phon; Ishwar Parhar
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.